Form D · Other Technology
Reify Health, Inc.
Boston, Ma, MA · CIK 0001570930
Offering snapshot reported Aug 10, 2021 · SEC filing
- Reported sold
- $220M Offering amount: $220M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 10, 2021 | Initial | $220,000,053 | No comparison | Not reported | SEC filing |
| Mar 1, 2013 | Initial | $330,000 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-409474
Source: Form D, filed Aug 10, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph T. Abrahamson | Promoter |
| Neeraj Agrawal | Director |
| Mark Fernandes | Director |
| David Fleshman | Director |
| Henry Li | Promoter |
| Michael Lin | Director, Executive |
| Ralph J. Passarella | Director, Executive |
| Robert Proctor | Director, Promoter |
Issuer details
Industry: Other Technology (See others in industry)
Address:
33 Arch Street, 17th Floor
Boston, Ma, MA, 02110
Boston, Ma, MA, 02110